Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up.

European journal of nuclear medicine and molecular imaging - 1 May 2015

Lepoutre-Lussey C, Caramella C, Bidault F, Déandreis D, Berdelou A, Al Ghuzlan A, Hartl D, Borget I, Gimenez-Roqueplo A-P, Dumont F, Deschamps F, Nascimento C, Lumbroso J, Guillaud Bataille M, Schlumberger M, Baudin E, Leboulleux S

Abstract excerpt

PURPOSE: Specific recommendations on screening modalities for paraganglioma (PGL) and phaeochromocytoma (PCC) in asymptomatic SDHx mutation carriers (relatives) are still lacking. We evaluated the added value of (18)F-FDG PET/CT in comparison with morphological imaging at initial diagnosis and 1 year of follow-up in this population. METHODS: The study included 30 consecutive relatives with a proven SDHx mutation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Asymptomatic Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorodeoxyglucose F18

Share to Multimodal Imaging

Share to Pheochromocytoma

Share to Positron-Emission Tomography

Share to Radiopharmaceuticals

Share to Succinate Dehydrogenase

Source

Identifiers

PMID: 25676472
DOI: 10.1007/s00259-015-3003-z

Genes

SDHD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up.PMID 25676472Read ↗

Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.Semantic proximity Read ↗

Can subunit‐specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers?Semantic proximity Read ↗

International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriersSemantic proximity Read ↗

Molecular imaging in hereditary succinate dehydrogenase mutation-related paragangliomas.Semantic proximity Read ↗

18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas.Semantic proximity Read ↗

Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or PheochromocytomaSemantic proximity Read ↗

Genetic status determines 18 F-FDG uptake in pheochromocytoma/paraganglioma.Semantic proximity Read ↗

Malignant phenotype and two SDHD mutations in a family with paraganglioma syndrome type 1.Semantic proximity Read ↗

Phenotype of SDHB mutation carriers in the Netherlands.Semantic proximity Read ↗

Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.Semantic proximity Read ↗

Modern PET imaging for paragangliomas: relation to genetic mutations.Semantic proximity Read ↗

High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PET.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.